ProPhase Labs, Inc. (PRPH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 50M 100M 150M FY09: 19.8M FY10: 14.5M FY11: 17.5M FY12: 22.4M FY13: 25M FY14: 22.1M FY15: 2.5M FY16: 4.2M FY17: 9.9M FY18: 13.1M FY19: 9.9M FY20: 14.5M FY21: 79M FY22: 122.6M FY23: 35M FY24: 6.8M FY25: 4.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

-25M 0 25M 50M 75M FY09: 11.6M FY10: 8.8M FY11: 11.3M FY12: 14.3M FY13: 16.7M FY14: 14.2M FY15: 832K FY16: 997K FY17: 1.9M FY18: 4.8M FY19: 2.6M FY20: 4.6M FY21: 42M FY22: 70.7M FY23: 15.6M FY24: -150K FY25: 1.4M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M FY09: -3.9M FY10: -3.6M FY11: -2.7M FY12: -1.1M FY13: 416K FY14: -7.8M FY15: -3.6M FY16: -2.7M FY17: -4M FY18: -1.6M FY19: -3.2M FY20: -2.1M FY21: 9.8M FY22: 23.6M FY23: -21.2M FY24: -38.6M FY25: -18M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-60M -40M -20M 0 20M 40M 60M FY09: -3.8M FY10: -3.5M FY11: -2.7M FY12: -1.1M FY13: 405K FY14: -7.8M FY15: -3.6M FY16: -2.9M FY17: 40.6M FY18: -1.7M FY19: -3.1M FY20: -2.1M FY21: 6.3M FY22: 18.5M FY23: -16.8M FY24: -53.4M FY25: -14.7M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 20M 40M 60M FY09: 8.2M FY10: 5.7M FY11: 6.2M FY12: 8.2M FY13: 8.4M FY14: 7.9M FY15: 1.7M FY16: 3.2M FY17: 7.9M FY18: 8.3M FY19: 7.3M FY20: 9.9M FY21: 37.1M FY22: 52M FY23: 19.4M FY24: 6.9M FY25: 3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

-20M -10M 0 10M 20M 30M FY09: 445K FY10: -3.5M FY11: -2.1M FY12: -5.7M FY13: 1.1M FY14: -3.2M FY15: -3.5M FY16: -472K FY17: -2.8M FY18: -2.1M FY19: -841K FY20: -2.6M FY21: -13.6M FY22: 28.6M FY23: -11.9M FY24: -17.5M FY25: -8.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-27M -18M -9M 0 9M 18M 27M FY09: 237K FY10: -3.7M FY11: -2.4M FY12: -6M FY13: 695K FY14: -3.5M FY15: -4.2M FY16: -1.1M FY17: -3M FY18: -2.3M FY19: -1.1M FY20: -4.3M FY21: -17.9M FY22: 24.6M FY23: -14M FY24: -18.4M FY25: -8.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 7M 14M 21M FY10: 14.3K FY11: 14.8M FY12: 14.8M FY13: 16.3K FY14: 16.8K FY15: 16.4M FY16: 17.1M FY17: 15.7M FY18: 11.4M FY20: 11.6M FY21: 18.4M FY22: 18.7M FY23: 17.2M FY24: 2M FY25: 8.5M FY10 FY12 FY14 FY16 FY18 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-30.00 -20.00 -10.00 0.00 10.00 20.00 30.00 Q1 '11: -0.24 Q3 '12: 0.13 Q4 '12: 0.29 Q4 '23: -0.98 Q1 '24: -1.37 Q2 '24: -1.50 Q3 '24: -1.55 Q4 '24: -26.70 Q1 '25: -25.21 Q2 '25: -25.96 Q3 '25: -25.77 Q4 '25: -1.66 Q1 '26: -3.21 Q2 '26: -2.35 Q3 '12 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.